Blood test markers for early kidney damage in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at two proteins in your blood (cathepsin S and chromogranin A) to see if they can help detect early kidney damage in people with type 2 diabetes. If they are useful, doctors might be able to find kidney problems earlier and start treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- You have either normal urine protein, small amounts of protein (microalbuminuria), or larger amounts (macroalbuminuria).
- You do not have kidney damage from a cause other than diabetes.
- You do not have type 1 diabetes, liver disease, heart failure, thyroid disorders, autoimmune diseases, inflammatory conditions, cancer, urinary tract infection, or are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study looks at how heart, kidney, and weight problems affect people with type 2 diabetes. It aims to find better ways to treat these related conditions and improve overall health.
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.